IS5333A - Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku - Google Patents

Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku

Info

Publication number
IS5333A
IS5333A IS5333A IS5333A IS5333A IS 5333 A IS5333 A IS 5333A IS 5333 A IS5333 A IS 5333A IS 5333 A IS5333 A IS 5333A IS 5333 A IS5333 A IS 5333A
Authority
IS
Iceland
Prior art keywords
side effects
treat glaucoma
prostaglandin derivatives
prostaglandin
derivatives
Prior art date
Application number
IS5333A
Other languages
English (en)
Inventor
Stjernschantz Johan
Resul Bahram
Lake Staffan
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20407743&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IS5333(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Publication of IS5333A publication Critical patent/IS5333A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IS5333A 1997-07-11 2000-01-07 Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku IS5333A (is)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9702706A SE9702706D0 (sv) 1997-07-11 1997-07-11 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma
PCT/SE1998/001368 WO1999002165A1 (en) 1997-07-11 1998-07-10 Prostaglandin derivatives devoid of side-effects for the treatment of glaucoma

Publications (1)

Publication Number Publication Date
IS5333A true IS5333A (is) 2000-01-07

Family

ID=20407743

Family Applications (1)

Application Number Title Priority Date Filing Date
IS5333A IS5333A (is) 1997-07-11 2000-01-07 Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku

Country Status (19)

Country Link
EP (1) EP1014991A1 (is)
JP (1) JP2002509543A (is)
KR (1) KR20010021682A (is)
CN (1) CN1169528C (is)
AU (1) AU739828B2 (is)
BR (1) BR9815501A (is)
CA (1) CA2294779A1 (is)
HK (1) HK1029942A1 (is)
HU (1) HUP0003106A3 (is)
IL (1) IL133871A (is)
IS (1) IS5333A (is)
NO (1) NO20000062D0 (is)
NZ (1) NZ501834A (is)
PL (1) PL337940A1 (is)
RU (1) RU2207858C2 (is)
SE (1) SE9702706D0 (is)
SK (1) SK183499A3 (is)
TR (1) TR200000008T2 (is)
WO (1) WO1999002165A1 (is)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9803761D0 (sv) * 1998-11-04 1998-11-04 Synphora Ab Method to avoid increased iridial pigmentation during prostaglandin treatment
EP1159266B1 (en) 1999-03-05 2004-11-03 Duke University C-16 unsaturated fp-selective prostaglandins analogs
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
US6531504B2 (en) * 2001-05-17 2003-03-11 Allergan, Inc. Prostanoic acid derivatives as agents for lowering intraocular pressure
GB0112699D0 (en) 2001-05-24 2001-07-18 Resolution Chemicals Ltd Process for the preparation of prostglandins and analogues thereof
US6713268B2 (en) * 2001-06-26 2004-03-30 Allergan, Inc. Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation
AU2003299137A1 (en) * 2002-09-16 2004-04-23 Texas Tech University System Inhibition of metallo-beta-lactamase
GB0501192D0 (en) 2005-01-20 2005-03-02 Resolution Chemicals Ltd Stable prostaglandin-containing compositions
PL212658B1 (pl) * 2005-04-18 2012-11-30 Inst Farmaceutyczny Sposób otrzymywania pochodnych 13,14-dihydro-PGF<sub>2</sub><sub>α</sub>
US8455513B2 (en) 2007-01-10 2013-06-04 Aerie Pharmaceuticals, Inc. 6-aminoisoquinoline compounds
JPWO2009133863A1 (ja) 2008-04-28 2011-09-01 国立大学法人浜松医科大学 Ｅｐ１アゴニストを含有してなる免疫増強剤
US8450344B2 (en) 2008-07-25 2013-05-28 Aerie Pharmaceuticals, Inc. Beta- and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds
EP3828172A1 (en) 2009-05-01 2021-06-02 Aerie Pharmaceuticals, Inc. Dual mechanism inhibitors for the treatment of disease
AU2009354014B2 (en) * 2009-10-16 2014-08-28 Cayman Chemical Company, Incorporated Process for the preparation of F-series prostaglandins
KR102070567B1 (ko) 2012-03-28 2020-01-29 메르크 파텐트 게엠베하 바이시클릭 피라지논 유도체
JP2012246301A (ja) * 2012-08-10 2012-12-13 Cayman Chemical Co Inc Ｆ系プロスタグランジン類を調製する方法
ES2852377T3 (es) 2013-03-15 2021-09-13 Aerie Pharmaceuticals Inc Sales dimesilato de 4-(3-amino-1-(isoquinolin-6-ilamino)-1-oxopropan-2-il)bencilo, sus combinaciones con prostaglandinas y el uso de las mismas en el tratamiento de trastornos oculares
US9643927B1 (en) 2015-11-17 2017-05-09 Aerie Pharmaceuticals, Inc. Process for the preparation of kinase inhibitors and intermediates thereof
MX2019002396A (es) 2016-08-31 2019-07-08 Aerie Pharmaceuticals Inc Composiciones oftalmicas.
CN110506037A (zh) 2017-03-31 2019-11-26 爱瑞制药公司 芳基环丙基-氨基-异喹啉酰胺化合物
US11427563B2 (en) 2018-09-14 2022-08-30 Aerie Pharmaceuticals, Inc. Aryl cyclopropyl-amino-isoquinolinyl amide compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4132738A (en) * 1978-02-23 1979-01-02 Miles Laboratories, Inc. Preparation of 15-deoxy-16-hydroxyprostaglandins
WO1994008585A1 (en) * 1992-10-13 1994-04-28 Alcon Laboratories, Inc. Combinations of prostaglandins and clonidine derivatives for the treatment of glaucoma

Also Published As

Publication number Publication date
JP2002509543A (ja) 2002-03-26
AU739828B2 (en) 2001-10-18
NO20000062L (no) 2000-01-06
TR200000008T2 (tr) 2000-05-22
WO1999002165A1 (en) 1999-01-21
BR9815501A (pt) 2001-07-17
RU2207858C2 (ru) 2003-07-10
SE9702706D0 (sv) 1997-07-11
NO20000062D0 (no) 2000-01-06
EP1014991A1 (en) 2000-07-05
PL337940A1 (en) 2000-09-11
IL133871A0 (en) 2001-04-30
IL133871A (en) 2004-09-27
KR20010021682A (ko) 2001-03-15
HUP0003106A3 (en) 2002-12-28
CN1169528C (zh) 2004-10-06
CA2294779A1 (en) 1999-01-21
AU8368398A (en) 1999-02-08
CN1262623A (zh) 2000-08-09
SK183499A3 (en) 2000-07-11
HK1029942A1 (en) 2001-04-20
HUP0003106A2 (hu) 2001-01-29
NZ501834A (en) 2002-05-31

Similar Documents

Publication Publication Date Title
IS5333A (is) Prostaglandínafleiður án hliðarverkana til að meðhöndla gláku
EE04390B1 (et) Paikne preparaat dermatoloogiliste seisundite raviks
DE69613368D1 (de) Chinazolin derivate
DE69613369D1 (de) Chinazolin derivate
DE69613367T2 (de) Chinazolin derivate
ID24314A (id) Tempat umpan bersekat-sekat
NO20002217L (no) Cyclopentan-heptansyre, 2-heteroarylalkenylderivater som terapeutiske midler
ATE211131T1 (de) Arylsulfonylaminohydroxamsäurederivate
IS2277B (is) Meðferðarlegar bíarýl afleiður
IT1283046B1 (it) Procedimento per riconoscere mancate combustioni
ID28441A (id) Terapi untuk memperbaiki kesadaran
NO20015227D0 (no) Fremgangsmåte for å öke effektiviteten til anti-cancer midler
IT1283827B1 (it) Procedimento per riconoscere mancate combustioni
PT921125E (pt) Derivados de 1,38-triaza-espiro 4,5 decan-4-ona
KR970000222A (ko) 팩리택셀 유도체의 전구약물
DE69805334D1 (de) Derivate des vitamin e
DK0747346T3 (da) N-acyl-2-arylcyclopropylmethylaminderivater som melatonerge midler
FI973362A0 (fi) Transdermaalinen formula
NO980923D0 (no) Optisk aktivt fenylpyrimidin-derivat som analgetisk middel
ID29792A (id) Formulasi lepas terkendali untuk mengobati corp
IT1282569B1 (it) Procedimento per riconoscere mancate combustioni
NO980862L (no) Zwitterionformer av trovafloxacin
DK0851856T3 (da) Indolderivater som melatoninerge analoger
ATE182133T1 (de) Naphtochinonderivate
NO951060D0 (no) Prostaglandin F-estere